CYP cynata therapeutics limited

9.68%

17.0¢

What questions do holders want asked at the AGM?, page-3

First 3 Last

Share
Profile

Follow
pfeifer1982

1,304 Posts.

3966

28/10/22

10:18

Post #: 64450177
Share

Originally posted by JB1975: ↑

re GvHD

Q2. Will management verify there is a high probability of recruiting 60 patients in a timely manner from specific centers (or centres) and countries prior to formerly committing to a phase 2 GvHD trial?

re Manufacturing and partnering

Q3. Will management advise if Fujifilm is ready, or how close it is to being ready, to manufacture cells for partners if partners were available?

Q4. Will management confirm that should they wish to prospective partners could still choose to use another manufacturer rather that Fujifilm, and so Fujifilm manufacturing would be an option for potential partners not an obligation?

Q5. Can management offer prospective partners a path toward 3D commercial scale manufacturing if partners were interested or do partners have to investigate potential IP arrangements and impediments or the lack of such with third parties themselves?

R and D

Q6. Has management considered prototyping 3D manufacturing using CYP MSCs at a small scale like in say a 5Litre bioreactor so as to be able to offer a proof of concept? Perhaps arranging with a university or engineering group to do the prototyping - then verifying the 2D and 3D manufactured cells are the same - and also establishing that micro carriers can be added and removed without problems for the cells?

Expand

Q4. Will management confirm that should they wish to prospective partners could still choose to use another manufacturer rather that Fujifilm, and so Fujifilm manufacturing would be an option for potential partners not an obligation?

https://www.fujifilmcdi.com/cynata-and-fujifilm-cellular-dynamics-execute-strategic-manufacturing-agreement

CYP Price at posting: 34.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 17.0¢		Change 0.015(9.68%)		Mkt cap ! $38.41M

Open	High	Low	Value	Volume
15.5¢	17.0¢	15.5¢	$47.10K	289.1K

Buyers (Bids)

No.	Vol.	Price($)
1	50000	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	23813	3

View Market Depth

No.	Vol.	Price($)
1	50000	0.165
4	47240	0.155
4	161673	0.150
1	5000	0.145
2	45000	0.140

Price($)	Vol.	No.
0.170	18813	2
0.175	55250	1
0.180	62619	3
0.185	35990	1
0.195	19300	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

CYP (ASX) Chart

What questions do holders want asked at the AGM?, page-3

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

What questions do holders want asked at the AGM?, page-3

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News